• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷脱氨酶缺乏症患者体内遗传性突变自发恢复正常。

Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency.

作者信息

Hirschhorn R, Yang D R, Puck J M, Huie M L, Jiang C K, Kurlandsky L E

机构信息

New York University Medical School, Department of Medicine, New York 10016, USA.

出版信息

Nat Genet. 1996 Jul;13(3):290-5. doi: 10.1038/ng0796-290.

DOI:10.1038/ng0796-290
PMID:8673127
Abstract

Somatic mosaicism in genetic disease generally results from a de novo deleterious mutation during embryogenesis. We now describe a somatic mosaicism due to the unusual mechanism of in vivo reversion to normal of an inherited mutation. The propositus was an adenosine deaminase-deficient (ADA-) child with progressive clinical improvement and unexpectedly mild biochemical and immunologic abnormalities. Mosaicism due to reversion was evidenced by absence of a maternally transmitted deleterious mutation in 13/15 authenticated B cell lines and in 17% of single alleles cloned from blood DNA, despite retention of a maternal 'private' ADA polymorphism linked to the mutation. Establishment of significant somatic mosaicism following reversion to normal could modify any disorder in which revertant cells have a selective advantage.

摘要

遗传疾病中的体细胞嵌合现象通常源于胚胎发育过程中发生的新生有害突变。我们现在描述一种由于遗传性突变在体内异常回复至正常的机制所导致的体细胞嵌合现象。该先证者是一名腺苷脱氨酶缺陷(ADA-)患儿,临床症状逐渐改善,且生化和免疫异常出人意料地轻微。尽管保留了与该突变相关的母亲“私人”ADA多态性,但在13/15个经鉴定的B细胞系以及从血液DNA克隆的单等位基因的17%中未检测到母亲传递的有害突变,这证明了由回复突变导致的嵌合现象。回复至正常后显著体细胞嵌合现象的形成可能会改变任何其中回复细胞具有选择优势的疾病。

相似文献

1
Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency.腺苷脱氨酶缺乏症患者体内遗传性突变自发恢复正常。
Nat Genet. 1996 Jul;13(3):290-5. doi: 10.1038/ng0796-290.
2
Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery.一名腺苷脱氨酶缺乏性免疫缺陷且有自发临床康复的患者中,新发现的剪接位点突变的体细胞镶嵌现象。
Am J Hum Genet. 1994 Jul;55(1):59-68.
3
Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.7例腺苷脱氨酶缺陷型联合免疫缺陷病迟发/延迟发病患者中的新型剪接、错义及缺失突变。基因型对表型的影响。
J Clin Invest. 1993 Nov;92(5):2291-302. doi: 10.1172/JCI116833.
4
Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).由于腺苷脱氨酶错义突变(Arg253Pro)纯合导致的严重程度降低的重症联合免疫缺陷。
Cell Immunol. 1993 Dec;152(2):383-93. doi: 10.1006/cimm.1993.1299.
5
Somatic mosaicism caused by monoallelic reversion of a mutation in T cells of a patient with ADA-SCID and the effects of enzyme replacement therapy on the revertant phenotype.患者 T 细胞中 ADA-SCID 突变的单等位基因回复引起的体体细胞嵌合现象,以及酶替代疗法对回复表型的影响。
Scand J Immunol. 2011 Nov;74(5):471-81. doi: 10.1111/j.1365-3083.2011.02593.x.
6
Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestry.腺苷脱氨酶(ADA)基因无义突变的携带者频率表明索马里ADA缺乏型重症联合免疫缺陷病(SCID)的发病率很高,且单一、常见的单倍型表明存在共同祖先。
Ann Hum Genet. 2007 May;71(Pt 3):336-47. doi: 10.1111/j.1469-1809.2006.00338.x. Epub 2007 Dec 19.
7
Female germ line mosaicism as the origin of a unique IL-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency.女性生殖系嵌合体是导致X连锁重症联合免疫缺陷的一种独特的白细胞介素-2受体γ链突变的起源。
J Clin Invest. 1995 Feb;95(2):895-9. doi: 10.1172/JCI117740.
8
Molecular basis of adenosine deaminase deficiency.腺苷脱氨酶缺乏症的分子基础。
Immunodeficiency. 1994;5(2):141-57.
9
Genotype is an important determinant of phenotype in adenosine deaminase deficiency.在腺苷脱氨酶缺乏症中,基因型是表型的重要决定因素。
Curr Opin Immunol. 2003 Oct;15(5):571-7. doi: 10.1016/s0952-7915(03)00104-3.
10
Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency.由遗传性腺苷脱氨酶缺乏引起的成人期免疫缺陷。
J Immunol. 1994 Sep 1;153(5):2331-9.

引用本文的文献

1
The interplay between germline and somatic variants in alpha-1 anti-trypsin deficiency liver disease.α-1抗胰蛋白酶缺乏性肝病中种系变异与体细胞变异之间的相互作用。
Nat Genet. 2025 Apr;57(4):775-776. doi: 10.1038/s41588-025-02151-z.
2
Selection for somatic escape variants in SERPINA1 in the liver of patients with alpha-1 antitrypsin deficiency.α-1抗胰蛋白酶缺乏症患者肝脏中SERPINA1体细胞逃逸变体的选择。
Nat Genet. 2025 Apr;57(4):875-883. doi: 10.1038/s41588-025-02125-1. Epub 2025 Mar 10.
3
Expanding the PRAAS spectrum: De novo mutations of immunoproteasome subunit β-type 10 in six infants with SCID-Omenn syndrome.
扩大 PRAAS 谱:6 例 SCID-Omenn 综合征婴儿免疫蛋白酶体亚基 β 型 10 的从头突变。
Am J Hum Genet. 2024 Apr 4;111(4):791-804. doi: 10.1016/j.ajhg.2024.02.013. Epub 2024 Mar 18.
4
Advances in gene therapy for inborn errors of immunity.免疫遗传性缺陷的基因治疗进展。
Curr Opin Allergy Clin Immunol. 2023 Dec 1;23(6):467-477. doi: 10.1097/ACI.0000000000000952. Epub 2023 Oct 13.
5
Homology-Directed-Repair-Based Genome Editing in HSPCs for the Treatment of Inborn Errors of Immunity and Blood Disorders.基于同源定向修复的造血干细胞基因组编辑用于治疗先天性免疫缺陷和血液疾病
Pharmaceutics. 2023 Apr 24;15(5):1329. doi: 10.3390/pharmaceutics15051329.
6
Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs.通过在人类造血干细胞中进行CRISPR基因组编辑实现用于重症联合免疫缺陷病(SCID)疾病及校正建模的多重同源定向修复(Multiplex HDR)
Mol Ther Nucleic Acids. 2022 Dec 9;31:105-121. doi: 10.1016/j.omtn.2022.12.006. eCollection 2023 Mar 14.
7
Gene therapy for inborn errors of immunity: past, present and future.免疫缺陷性遗传病的基因治疗:过去、现在和未来。
Nat Rev Immunol. 2023 Jun;23(6):397-408. doi: 10.1038/s41577-022-00800-6. Epub 2022 Nov 25.
8
Revertant Mosaicism in Genodermatoses: Natural Gene Therapy Right before Your Eyes.遗传性皮肤病中的回复性镶嵌现象:就在你眼前的天然基因疗法。
Biomedicines. 2022 Aug 29;10(9):2118. doi: 10.3390/biomedicines10092118.
9
Management of Inborn Errors of Immunity in the Genomic Era.基因组时代遗传性免疫缺陷病的管理
Turk Arch Pediatr. 2022 Mar;57(2):132-145. doi: 10.5152/TurkArchPediatr.2022.22033.
10
Reversion Mosaicism in Primary Immunodeficiency Diseases.原发性免疫缺陷病中的回复性嵌合体。
Front Immunol. 2021 Nov 16;12:783022. doi: 10.3389/fimmu.2021.783022. eCollection 2021.